Business Context and Reporting Period
This Form 8-K Current Report was filed by Keros Therapeutics, Inc. on June 1, 2026. The filing serves as a Regulation FD disclosure regarding an upcoming corporate event rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference.
- Date and Time: Monday, June 8, 2026, at 4:00 p.m. Eastern time.
- Legal Status: The information in this report and the accompanying press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Goldman Sachs 47th Annual Global Healthcare Conference presentation (June 8, 2026, 4:00 p.m. ET).
- Confirm the availability of the press release (Exhibit 99.1) for details on the presentation topic.
- Note that this filing contains no new financial data; investors should refer to the most recent 10-K or 10-Q for financial status.